SCHEMBL1505035

SCHEMBL1505035

COCCOCOc1ccc(C(=O)NCC([C@H](C)O)N2CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.48
ADAM17 P78536 2/20 0.48
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
RECQL P46063 1/20 0.45
PKM P14618 1/20 0.44
MAPK1 P28482 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
FAAH O00519 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505034 1.00 CYP2D6 (0.48) CYP2D6ADAM17HDAC4HDAC1ALDH1A1
SCHEMBL10276327 0.89 ADAM17 (0.57) CYP2D6ADAM17HDAC4HDAC1ALDH1A1
SCHEMBL10276320 0.89 ADAM17 (0.57) CYP2D6ADAM17HDAC4HDAC1ALDH1A1
SCHEMBL10476316 0.86 ADAM17 (0.48) CYP2D6ADAM17HDAC4HDAC1ALDH1A1
SCHEMBL10476319 0.86 ADAM17 (0.48) CYP2D6ADAM17HDAC4HDAC1ALDH1A1
SCHEMBL10475842 0.74 ADAM17 (0.55) ADAM17ALDH1A1KDM4EMAPT
SCHEMBL10475882 0.74 ADAM17 (0.55) ADAM17ALDH1A1KDM4EMAPT
SCHEMBL10275951 0.73 ADAM17 (0.55) ADAM17
SCHEMBL10275940 0.73 ADAM17 (0.55) ADAM17
SCHEMBL10275880 0.72 ADAM17 (0.44) ADAM17ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033009-A1 N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed